These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6814773)

  • 1. Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.
    Czarneztki BM
    Chem Phys Lipids; 1982 Oct; 31(2):205-11. PubMed ID: 6814773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of synthetic PAF-acether on human neutrophil function.
    Czarnetzki BM; Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased biosynthesis of platelet-activating factor in activated human eosinophils.
    Lee T; Lenihan DJ; Malone B; Roddy LL; Wasserman SI
    J Biol Chem; 1984 May; 259(9):5526-30. PubMed ID: 6425292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding sites for 1-O-alkyl-sn-glyceryl-3-phosphorylcholine on intact human blood neutrophils.
    Korth RM
    Int Arch Allergy Immunol; 1997 Aug; 113(4):460-4. PubMed ID: 9250592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
    Sugiura T; Fukuda T; Masuzawa Y; Waku K
    Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
    Jouvin-Marche E; Poitevin B; Benveniste J
    Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
    Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
    J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).
    Sigal CE; Valone FH; Holtzman MJ; Goetzl EJ
    J Clin Immunol; 1987 Mar; 7(2):179-84. PubMed ID: 3571436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.
    Czarnetzki BM; Benveniste J
    Chem Phys Lipids; 1981 Dec; 29(4):317-26. PubMed ID: 7318049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
    Triggiani M; Goldman DW; Chilton FH
    Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.